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Background: Ucche (Momordica charantia L. var. muricata (Willd.) Chakravarty) has been reported to possess many
benefits and medicinal properties. However, the protective effect of ucche against carbon tetrachloride (CCl4)
induced hepatotoxicity have not been clarified fully yet. The aim of the present study was to investigate the effects
of ucche on oxidative stress and inflammation in liver of CCl4 treated rats.
Methods: Female Long Evans rats were administered with CCl4 orally (1 ml/kg) twice a week for 2 weeks and were
supplemented with freshly prepared crashed ucche (10% wt/wt of diet) with powdered chaw food. Both plasma
and liver tissues were analyzed for AST, ALT and ALP activities. Oxidative stress parameters were measure by
determining malondialdehyde (MDA), nitric oxide (NO), advanced protein oxidation product (APOP), and reduced
glutathione (GSH) concentrations and catalase activities in plasma and liver tissues. Moreover, inflammation and
tissue fibrosis were confirmed by histological staining of liver tissue sections.
Results: Our data suggest that ucche significantly prevented CCl4-induced hepatotoxicity, indicated by both diagnostic
indicators of liver damage (serum transferases activities) and histopathological analysis. Moreover, CCl4 administration
induced profound elevation of reactive oxygen species (ROS) production and oxidative stress, as evidenced by
increasing lipid peroxidation level and depletion of antioxidant enzymes in liver. Fresh ucche supplementation
prevented the oxidative stresses and improved antioxidant enzyme function. Furthermore, fresh ucche supplementation
reduced hepatic inflammatory cell infiltration, iron deposition and fibrosis in liver of CCl4 treated rats.
Conclusion: In conclusion, these results suggested that the inhibition of CCl4-induced inflammation by ucche is due at
least in part to its anti-oxidant activity and its ability to modulate the inflammation and fibrosis in liver.
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Liver is the main organ for nutrition metabolism and de-
toxifying foreign chemical agents in living animals. Other
functions of liver are helping digestion, production of
invaluable endogenous hormones, enzymes as well as
production of glucose while fasting. However, hepatic* Correspondence: sonaliagun@yahoo.com
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unless otherwise stated.dysfunctions like cirrhosis, steatosis, hepatitis as well
as drug induced hepatic damages are increasing day by
day [1]. Oxidative stress has been proposed to be in-
creased in most cases of liver dysfunction mentioned
above. Carbon tetrachloride (CCl4) is a well known
hepatotoxin used extensively for the study hepatotox-
icity in animal models. CCl4 stimulates bio-activation
of the phase I cytochrome P450 system to form reactive
metabolic trichloromethyl radicals (•CCl3) and peroxy tri-
chloromethyl radicals (•OOCCl3) [2]. These peroxy radi-
cals stimulate kupffer cells to produce ROS, such as •O2
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•OH, which thus causes lipid peroxidation and
reported to induce acute and chronic tissue injuries [3,4].
Free radicals generated by CCl4 are thus responsible for
the membrane disintegration of hepatocytes which subse-
quently release marker enzymes of hepatotoxicity such
as aspartate transaminase (AST), alanine transaminase
(ALT), alkaline phosphatase (ALP) and lactate dehydro-
genase (LDH) [5]. Centrilobular necrosis and steatosis are
also commonly seen in CCl4- induced liver toxicities [5,6].
Inflammation and fibrosis are some other early events
which may also occur during the progression of the liver
damage due to CCl4 challenge [7,8].
Bitter melon (Momordica charantia) is a culinary bitter
vegetable commonly used in traditional dishes in Bangladesh
and Indian subcontinent [9]. Bitter melon can be found in
different shapes and sizes. Generally, two varieties of bitter
melon are found, mainly karela (Momordica charantia
L. var. charantia C. B. Clarke) and ucche (Momordica
charantia L. var. muricata (Willd.) Chakravarty). Karela
is 20–30 cm long, oblong with bluntly tapering ends and
pale green in color, while ucche is only 6–10 cm in length
and has a narrower shape with pointed ends, and a dark
green surface covered with jagged, triangular “teeth” and
ridges. Both varieties are also used as a traditional medi-
cine for the treatment of diabetes and other stomach
complaints in Bangladesh. Recent evidences suggest
that Momordica charantia extract may improve insulin
resistance [10] and lowers plasma lipid profile in dia-
betic and obese experimental animals [11,12]. Momordica
charantia extract also improved antioxidant status and
prevents oxidative stress in vivo [13]. Several bioactive
molecules were isolated from Momordica charantia leaves,
fruits and seeds [14-17]. Gallic acid, tannic acid, (+)-catechin,
caffeic acid, p-coumaric, gentisic acid, chlorogenic acid,
and epicatechin have been isolated from various parts
of Momordica charantia plants [18]. Moreover, cucur-
bitane type triterpenoids such as charantin, kuguacins,
momordicin, and karavilagenins were also isolated from
Momordica charantia [18]. The extract also showed anti-
oxidant activities in various experimental models [19].
However, karela variety is extensively studied in most sci-
entific research reported to date, whereas ucche variety is
less explored for any proper scientific evaluation. Thus,
the current study was undertaken to evaluate the thera-
peutic benefit of ucche in oxidative stress, inflammation,
fibrosis and liver damage induced by CCl4 treated rats.
Methods
Plant material and preparation of extracts
Momordica charantia fruits were purchased from a local
vegetable market in Dhaka, Bangladesh. This plant has
been identified by the expert Mr. Sarker Nasir Uddin,
Senior Scientific Officer, of National Herberium, Mirpur,
Dhaka Bangladesh and a voucher specimen was deposited(Acc No. 40566) for future reference. Fresh fruits (250 g)
were taken and cut into small pieces and macerated in
electrical blander without adding any water. This suspen-
sion was used as a supplementation to add with powder
food (10% W/W of diet).
Animals and treatment
Ten to twelve weeks old, 24 Long Evans female rats
(150–210 g) were obtained from Animal production unit
of Animal House at Department of Pharmaceutical
Sciences, North South University and were kept in in-
dividual cages at room temperature of 25 ± 3°C with a
12 h dark/light cycles. They have free access to stand-
ard laboratory feed (Pellet food was crushed to powder)
and water, according to the study protocol approved by
Ethical Committee of Department of Pharmaceutical
Sciences, North South University for animal care and
experimentation. To study the hepatoprotective effects
of Ucche, rats were equally divided into four groups
(six rats each): Group I (Control), Group II (Control +
Ucche), Group III (CCl4) and Group IV (CCl4 + Ucche).
Animals of group I and II were treated with 1 ml/kg of sa-
line (0.85%) and olive oil (1 ml/kg) intragastrically twice a
week for two weeks. Rats of group II were supplanted with
Ucche fruit in powder food (10% of powder food, w/w).
Rats of group III and IV were treated with CCl4 (1:3 in
olive oil) at a dose of 1 ml/kg intragastrically twice a week
for two weeks. Animals of group III received only CCl4
treatment; however, animals of group IV received ucche
fruit crashed in powder food (10% of powder food, w/w)
along with CCl4 treatment. Animals were checked for the
body weight, food and water intake on a daily basis. After
14 days all animals were weighted, sacrificed, collected the
blood and all internal organs such as heart, kidney, spleen
and liver. Immediately after collection of the organs, they
were weighted and stored in neutral buffered formalin
(pH 7.4) for histological analysis and in refrigerator at −20°C
for further studies. Collected blood was centrifuged at
8000 rpm and separated the plasma and stored in refriger-
ator at −20°C for further analysis.
Assessment of hepatotoxicity
Liver marker enzymes (alanine aminotransferase (ALT),
aspartate aminotransferase (AST), and alkaline phosphat-
ase (ALP) were estimated in plasma by using Diatech
diagnostic kits (Hungary) according to the manufacturers
protocol.
Preparation of tissue sample for the assessment of
oxidative stress markers
For determination of oxidative stress markers, liver tis-
sue was homogenized in 10 volumes of Phosphate buffer
containing (pH 7.4) and centrifuged at 12,000 × g for
30 min at 4°C. The supernatant was collected and used
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as described below.Estimation of lipid peroxidation
Lipid peroxidation in liver was estimated colorimetrically
measuring malondialdehyde (MDA) followed by previ-
ously described method [20]. In brief, 0.1 ml of tissue
homogenate (Tris–HCl buffer, pH 7.5) was treated with
2 ml of (1:1:1 ratio) TBA-TCA-HCl reagent (thiobarbitu-
ric acid 0.37%, 0.25 N HCl and 15% TCA) and placed in
hot water bath for 15 min and cooled. The absorbance
of clear supernatant was measured against reference
blank at 535 nm.Estimation of nitric oxide (NO)
Nitric oxide (NO) was determined according to the
method described by Tracy et al. as nitrate and nitrite
[21]. In this study, Griess-Illosvoy reagent was modified
by using naphthyl ethylene diamine dihydrochloride
(0.1% w/v) instead of 1-napthylamine (5%). The reac-
tion mixture (3 mL) containing brain homogenates
(2 mL) and phosphate buffer saline (0.5 mL) was incu-
bated at 25°C for 150 min. A pink colored chromophore
was formed which was measured at 540 nm against the
corresponding blank solutions with a spectrophotometer.
NO level was calculated as nitrate by using Sodium nitrate
standard curve and expressed as nmol/mL.Estimation of Advanced protein oxidation products
(APOP)
APOP level was performed using previously described
method reported by Witko-Sarsat [22] and Tiwari [23].
Two mL of plasma was diluted (1:5) in PBS, 0.1 mL po-
tassium iodide (1.16 M) was then added to each tube,
followed by 0.2 mL acetic acid after 2 min. The absorb-
ance of the reaction mixture was immediately read at
340 nm against a blank containing 2 mL of PBS, 0.1 mL
of KI, and 0.2 mL of acetic acid. The chloramine-T ab-
sorbance at 340 nm was found linear within the range of
0 to 100 nmol/mL, APOP concentrations were expressed
as nmol · mL−1 chloramine-T equivalents.Estimation of catalase (CAT) activity
CAT activities were determined using previously de-
scribed method [24,25] with some modifications. The re-
action solution of CAT activities contained: 2.5 ml of
50 mmol phosphate buffer (pH 5.0), 0.4 ml of 5.9 mmol
H2O2 and 0.1 ml enzyme extract. Changes in absorbance
of the reaction solution at 240 nm were determined after
one minute. One unit of CAT activity was defined as an
absorbance change of 0.01 as units/min.Estimation of reduced glutathione (GSH)
Reduced glutathione was estimated by the method of
Jollow et al. [26]. The total volume of 3.0 ml assay mixture
composed of 0.1 ml filtered aliquot, 2.7 ml phosphate buf-
fer (0.1 M, pH 7.4) and 0.2 ml DTNB (5,5-dithiobis-2-
nitrobenzoic acid), (100 mM). The yellow color of the
mixture was developed, read immediately at 412 nm on a
Smart SpecTM plus Spectrophotometer and expressed as
ng/mg protein.
Histopathalogical assessments
For microscopic evaluation liver tissues were fixed in neu-
tral buffered formalin and embedded in paraffin, sectioned
at 5 μm and subsequently stained with hematoxylin/eosin
to see the architecture of hepatic tissue and inflammatory
cell infiltration. Sirious red staining for fibrosis and prus-
siun blue staining for iron deposition were also done in
liver sections. Sections were then studied and photo-
graphed under light microscope (Zeiss Axioscope) at 40X
magnifications.
Statistical analysis
All values are expressed as mean ± standard error of
mean (SEM). The results were evaluated by using the
Two way or One-way ANOVA followed by Bonferroni
test using Graph Pad Prism Software, version 6. Statis-
tical significance was considered p < 0.05 in all cases.
Result
Effect on body weight, food and water intake
Body weight of each rat was recorded every day during
the experiment, and % change was calculated for all
groups. It was found that the body weights of rats were
decreased in CCl4 treated rats compared to the control
(Figure 1). However, ucche supplementation did not im-
prove the weight reduction in CCl4 treated rats. Moreover,
CCl4 intoxicated group significantly decreased food and
water intake compare to control rats, reduction of food
and water intake was further improved in ucche treated
group (Figure 1).
Effect on organ wet weight
Table 1 shows the effect of various treatments on the
rats’ organs weight. The spleen wet weight was signifi-
cantly (p < 0.05) increased in the CCl4-treated rats com-
pared to control group rats. Ucche (10% per kg of diet)
treatment was significantly (p < 0.05) attenuated the wet
weight gain of the spleen in the CCl4-treated rats. Moreover,
CCl4-treated rats showed slight decrease in liver wet weight,
however, ucche (10% per kg of diet) treatment did not
change the wet weight of the liver compared to the control
(Table 1). Another crucial finding in this study was the re-
duction of kidney wet weight due to CCl4 intoxication.
Apart from these findings, CCl4 intoxication increased the
Figure 1 Effect of bitter melon (Ucche) on body weight (A), food intake (B) and water intake (C) in CCl4 treated rats.
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supplementation (Table 1).
Effect on biochemical parameter of liver functions
Biochemical measurement of liver functions revealed
that, CCl4 induced a significant increase in plasma AST,
ALT, and ALP activity compared with control values,
respectively (Table 2). Treatment of animals with ucche
(10% per kg of diet) concomitantly with CCl4 significantly
counteracted the alteration in all hepatotoxicity indices
compared to the CCl4-intoxicated group. In addition,
treatment of animals with ucche alone for 2 weeks did not
show any significant change in liver enzymes compared
with the control group (Table 2).
Oxidative stress markers and antioxidant enzymes
To determine the oxidative stress in our study, we evalu-
ated the MDA, nitric oxide and APOP content in plasma
and liver homogenates. CCl4 induced rats showed a higher
concentration of lipid peroxidation product MDA both in
plasma and liver homogenates (Table 2) (7.7 ± 0.91 andTable 1 Effect of bitter melon (Ucche) on body weight, food a
Parameters Control Control + Ucche CCl4
Initial Body weight 144.15 ± 4.65 146.93 ± 4.51 155.67 ± 7
Final Body weight 175.83 ± 1.90 147.00 ± 3.81 146.68 ± 8
Food intake/d 17.8 ± 0.64 14.75 ± 0.60 11.08 ± 0.
Water intake/d 20.58 ± 0.77 16.94 ± 0.89 11.80 ± 0.
Liver wet weight 6.09 ± 0.36 5.25 ± 0.10 5.62 ± 0.2
Kidney wet weight 1.04 ± 0.07 0.95 ± 0.03 0.86 ± 0.0
Heart wet weight 0.42 ± 0.02 0.46 ± 0.01 0.52 ± 0.0
Spleen wet weight 0.49 ± 0.06 0.58 ± 0.02 0.81 ± 0.0
Values are presented as mean ± SEM. N = 5-7 in each group or otherwise specified.
Values are considered significance at p < 0.05. a vs b, control vs CCl4; b vs c, CCl4 vs57.16 ± 6.44 nmol/mL in plasma and liver homogenates
respectively). Additionally, ucche (10% per kg of diet)
co-treatment significantly reduced the level of lipid
peroxides compared to CCl4 intoxicated group (6.71 ±
0.77 and 36.92 ± 1.98 nmol/mL in plasma and liver ho-
mogenates respectively); however, lipid peroxide level
was still higher than the control.
CCl4 have profound effect on APOP development in
plasma and liver. CCl4 challenge significantly increased
the APOP concentration in plasma and liver (164.4 ± 15.15
and 1357.62 ± 91.06 nmol/mL equivalent to Chloramine-T
respectively) which was decreased due to ucche (10%
per kg of diet) supplementation in CCl4 intoxicated
rats (84.3 ± 8.8 and 977.50 ± 63.05 nmol/mL equivalent
to Chloramine-T respectively).
Nitric oxide measured as nitrate was also increased
both in plasma and liver homogenates (5.8 ± 0.3 and
35.62 ± 4.21 nmol/mL in plasma and liver homogenates
respectively) compared to control rats which was nor-
malized by ramipril treatment in CCl4 intoxicated group
(Table 2). CCl4 induced a significant decrease in livernd water intake and organ weight of CCl4 treated rats
CCl4 + Ucche p values
CCl4 Treatment Interaction
.13 133.14 ± 3.19 0.0752 0.8310 0.0261
.33 133.90 ± 5.89 0.0013 0.0012 0.1630
46 16.74 ± 0.81 0.0013 0.0509 <0.0001
41 13.72 ± 0.54 0.7271 0.0722 0.7751
5 4.93 ± 0.47 <0.0001 0.2282 0.0134
4 0.71 ± 0.19 0.5910 <0.0001 0.9141
1 0.45 ± 0.05 0.1995 <0.0001 0.1995
9 0.58 ± 0.04 <0.0001 0.3009 0.0067
Two way or One way ANOVA with Bonferoni tests were done as post hoc test.
ucche treatment.
Table 2 Effect of bitter melon (ucche) on biochemical parameter in plasma and liver
Parameters Groups p values
Control Control + Ucche CCl4 CCl4 + Ucche CCl4 Treatment Interaction
Plasma
AST(U/L) 19.0 ± 1.6 21.32 ± 1.68 37.9 ± 3.1 23.3 ± 4.0 0.0374 0.0012 0.0062
ALT(U/L) 13.8 ± 1.7 16.59 ± 2.62 30.5 ± 3.1 18.7 ± 1.9 0.0831 0.0012 0.0082
ALP(U/L) 50.8 ± 3.3 50.92 ± 2.76 81.2 ± 6.1 63.9 ± 4.7 0.0731 0.0001 0.0690
MDA(nmol/mL) 6.34 ± 0.37 3.57 ± 0.54 7.7 ± 0.91 6.71 ± 0.77 0.0731 0.0001 0.0690
NO (nmol/mL) 3.22 ± 0.27 2.24 ± 0.22 5.8 ± 0.3 1.15 ± 0.32 <0.0001 0.0195 <0.0001
APOP (nmol/mL equivalent to Chloramine-T) 82.60 ± 8.49 67.0 ± 9.2 164.4 ± 15.15 84.3 ± 8.8 0.0340 0.0102 0.3072
Catalase (U/min) 6.00 ± 0.32 4.28 ± 0.38 2.93 ± 0.60 5.07 ± 0.74 0.6960 0.0343 0.0011
GSH (ng/mg protein) 20.05 ± 1.81 18.39 ± 1.03 12.72 ± 0.57 16.39 ± 0.57 0.3788 0.0005 0.0270
Liver
AST(U/L) 36.18 ± 3.22 31.01 ± 3.46 65.18 ± 3.87 46.51 ± 2.11 0.0023 <0.0001 0.0594
ALT(U/L) 26.00 ± 3.88 34.67 ± 2.24 77.61 ± 4.80 28.77 ± 1.49 <0.0001 <0.0001 <0.0001
ALP(U/L) 30.33 ± 3.67 31.42 ± 3.54 113.53 ± 3.71 68.25 ± 3.67 <0.0001 <0.0001 <0.0001
NO (nmol/mL) 15.87 ± 1.56 20.21 ± 0.45 35.62 ± 4.21 18.11 ± 2.17 0.0225 0.0036 0.0006
MDA (nmol/mL) 21.85 ± 1.86 24.62 ± 4.88 57.16 ± 6.44 36.92 ± 1.98 0.0741 <0.0001 0.0226
APOP (nmol/mL equivalent to Chloramine-T) 365.00 ± 40.19 450.0 ± 75.83 1357.62 ± 91.06 977.50 ± 63.05 0.0491 < 0.0001 0.0097
Catalase (U/min) 52.13 ± 4.02 68.40 ± 5.92 26.32 ± 3.82 50.27 ± 2.33 0.0003 < 0.0001 0.3967
GSH (ng/mg protein) 21.22 ± 1.91 19.22 ± 1.13 45.98 ± 5.05 32.89 ± 1.79 0.0171 < 0.0001 0.0703
Values are presented as mean ± SEM. N = 5-6 in each group or otherwise specified. Two way or One way ANOVA with Bonferoni tests were done as post hoc test.
Values are considered significance at p < 0.05. a vs b, control vs CCl4; b vs c, CCl4 vs ucche treatment. APOP-Advanced protein oxidation product, expressed as
nmol/mL equivalent to Chloramine-T.
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ively, compared to the control levels. In addition, CCl4
induced a significant increase in lipid peroxide level by
more than four folds compared with the control group
(Table 2). Treatment of animals with ucche (10% per kg
of diet) concomitantly to CCl4 significantly counteracted
the oxidative stress effect of CCl4. It was found that, the
level of GSH and CAT activity restored near normal
compared to CCl4 intoxicated group (Table 2).
Inflammation, fibrosis iron deposition in liver
Inflammation was seen in rats treated with CCl4. Massive
serge of inflammatory cells was found in the centilobular
part of liver section stained with H & E staining in CCl4
treated rats group (Figure 2C). Necrotized tissue scar and
ballooning of the hepatocytes were also seen in liver of
CCl4 treated rats. ucche (10% per kg of diet) co-treatment
attenuated the inflammatory cell infiltration and necrosis
in the liver tissues of CCl4 treated rats (Figure 2D). Liver
fibrosis was evaluated by histologically by visualizing the
red color of collagen fibers using Sirius red stain. In con-
trast, the collagen fibers were heavily deposited around
portal tracts and central veins in CCl4-intoxicated group
and extended from central vein to portal tract resulting in
the formation of pseudolobules (Figure 2G). Histological
staining also revealed massive iron deposition in liversection stained for free iron depot in CCl4 treated rats
(Figure 3C). Ucche supplementation decreased this iron
deposition in CCl4 treated rats (Figure 3D).
Discussion
Liver is one of the vital organs in our body responsible
for detoxification of toxic chemicals and drugs. Chronic
liver diseases are increasing in recent years and the med-
ical treatments for these diseases are usually difficult to
handle and showed limited efficacy. Therefore, it is ne-
cessary to find new alternative treatment for the man-
agement of liver diseases. CCl4 treatment is one of the
most used methods for the study of experimental hep-
atic dysfunction nowadays; however, CCl4 is considered
as an extremely toxic chemical agent [27]. Several im-
portant basic mechanisms involving of tissue damages
induced by CCl4 have been proposed, such as reactive
free radical metabolites, lipid peroxidation, metabolic ac-
tivation, covalent binding and disturbance of calcium
homeostasis [3]. The present study demonstrates that
fresh ucche supplementation prevented oxidative stress,
lowered inflammatory cell infiltration and fibrosis in
liver and improved the hepatic enzymes function against
CCl4-induced liver injury in rats.
Oxidative stress is the major cause of tissue damage in
CCl4 treated animal model of hepatic dysfunction. CCl4
Figure 2 Effect of bitter melon (Ucche) on hepatic inflammation and fibrosis in CCl4 treated rats. A, E- Control; B, F- Control + Ucche;
C, G- CCl4 and D, H- CCl4+ Ucche. Magnification 40x. ic-inflammatory cells; fb- fibrosis.
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into the free radical •CCl3 [28,29]. The free radical at-
tacks hepatocytes and causes necrosis of parenchymal
cells. We found that the concentration of MDA and
APOP, which are indices of oxidative stress, were ele-
vated in CCl4-challenged rats. However, decreased con-
centrations of these two compounds were found in
plasma and the liver tissues of those CCl4-rats that were
treated with ucche supplementation, which suggests that
fresh ucche can effectively protect against lipid peroxida-
tion and protein oxidation. Similar results were also re-
ported by other investigators that fruit extract (300 mg/kg)
and the plant extract at a dose of 5 ml/kg also produced
significant protection of liver damage by preventing ele-
vated TBARS and hydroperoxides concentration and
increased the levels of glutathione peroxidase (GPx),Figure 3 Effect of ucche on hepatic iron deposition in CCl4 treated
Blue dots- iron pigment, Magnification 40x.superoxide dismutase (SOD), catalase and reduced gluta-
thione in ammonium chloride-induced toxicity in rats
[13,30]. Catalase is an important antioxidant enzymes re-
sponsible for the scavenging of free radical generated in
tissue. Catalase enzyme exists in all aerobic cells, is a
hemeprotein that metabolizes the H2O2 to form oxygen
and water. Szymonik-Lesiuk et al. reported that CCl4 in-
toxication leads to changes in antioxidant enzymes activity
[31]. In our study, CCl4 treatment causes breakdown of
catalase mediated prevention of tissue damage and low-
ered the catalase activity which was further improved to
near normal by ucche supplementation. Oxidative stress
mediated tissue damage also increases the liver marker en-
zyme activities. Damage to the liver typically results in
leakage of AST and ALT into the bloodstream [32]. In
the present study CCl4 administration to rats caused arats. A- Control; B- Control + Ucche; C- CCl4 and D- CCl4+ Ucche.
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ity which were further normalized by ucche supple-
mentation. Nitric oxide is another mediator of oxidative
stress despite of its valuable role in the maintenance of
vascular tone and as signaling molecule. However, excess
production of nitric oxide by iNOS may lead to hepatic in-
jury which can be reversed by scavenging of nitric oxide
[33,34]. Ucche supplementation also reduces the elevated
nitrate concentration in plasma and tissues of CCl4 treated
rats. Our results are also comparable to Chaudhari et al.
who reported that hydroalcoholic extract of the plant
leaves (100 and 200 mg/kg) normalized the levels of
SGOT, SGPT, ALP, total bilirubin and prevented steatosis,
centrilobular necrosis and vacuolization in liver of car-
bon tetrachloride induced liver damage in rats [35].
Similar findings were also reported in another study
that investigated the hepatoprotective effects of plant
bioactive compounds against CCl4-induced injury in
rats hepatocytes [36].
Moreover, oxidative stress mediated tissue damage
may trigger inflammation and fibrosis in liver of CCl4
treated rats. Liver fibrosis is also characterized by a dis-
tortion of liver tissue architecture and an excessive de-
position of extra cellular matrix (ECM) proteins that
type I collagen predominates [7]. Hepatic stellate cells
(HSCs) have been recognized as the main matrix-
producing cells in the process of liver fibrosis. Kupffer
cells (KCs) could activate HSCs by producing and releas-
ing a variety of mediators, such as proinflammatory cy-
tokines and reactive oxygen species that fulfill a crucial
function in the inflammatory responses of the liver [37].
Histological examination also demonstrated that a large
number of inflammatory cells infiltrated into the intra-
lobular and interlobular regions together with increased
collagen fibers in CCl4 treated rats compared with nor-
mal rats. On the contrary, ucche supplementation re-
markably reduced the immigration of inflammatory cells
and the deposition of collagen fibers compared with rats
in model group treated with CCl4.
Another key finding in our model is the deposition of
iron in hepatic tissues assessed through histologically by
iron staining. Iron deposition is characteristics of many
forms of liver diseases including viral hepatitis-C, alco-
holic and nonalcoholic hepatitis [38,39]. In hepatic dis-
eases, the Kupffer cells (KC) and liver cells are not
capable of processing the iron due to heam oxygenase
deficiency and deposited in the tissue which further con-
tributes to oxidative tissue damage by fenton reaction
[40-42]. Previous authors also reported that iron over-
load can enhance the development of liver cirrhosis in
animal models [43,44]. Clinical evidence also noted that
iron-loaded livers of hemochromatosis patients were also
found to exhibit oxidative stress and enhanced expres-
sion of TGF-β1 [45]. TGF-β1 is the key regulatorygrowth factor secreted by fibroblast cells due to activa-
tion by inflammatory stimuli and oxidative stress [46].
Thus, the deposited iron can also accelerate the advance-
ment of liver fibrosis by increasing α1-(I)-collagen mRNA
expression [47]. In our study, ucche supplementation sig-
nificantly reduced the iron deposition and fibrosis in liver
of rats treated with CCl4 further confirmed the reduction
of oxidative stress in liver.
Phenolic or polyphenolic compounds are potent anti-
oxidants and are capable of preventing oxidative stress
in various diseases including liver damage [48]. Previous
reports suggest that various phenolic compounds such
as gallic acid, tannic acid, (+)-catechin, caffeic acid,
p-coumaric, gentisic acid, chlorogenic acid, and epi-
catechin are present in Momordica charantia plants
[14,15]. Our analysis (unpublished data) on ucche fruit
extract showed that ellagic acid and myricetin are present
in abundant amount. Ellagic acid showed preventive effect
in isoniazid-rifampicin induced liver damage [49] and
cisplatin-induced oxidative stress in liver [50]. Myricetin
are also effective in lowering plasma lipids (which is one
of the mechanism of hepatic protection in non alcoholic
fatty liver like diseases), in high fat diet fed animals [51].
However, it is not possible to speculate which phenolic
compound responsible for the preventive activity in liver
showed by ucche supplementation in this study, probably
a combined effects of all phenolic compounds play their
role and gave a synergistic effect.
Conclusions
In conclusion, our findings revealed that ucche supple-
mentation has a protective effect against CCl4 induced
hepatotoxicity. The hepatoprotective effects of ucche
supplementation are likely related to the prevention of
oxidative stress by increasing antioxidant activity, lower-
ing lipid peroxidation, and improving the function of
liver cells. Moreover, ucche supplementation also pro-
motes hepatic protection by decreasing inflammation
and fibrosis probably mediated by inhibiting iron medi-
ated signaling pathways and HSCs activation. Further
studies are needed to investigate the molecular mechan-
ism of the hepatoprotective effect of ucche supplementa-
tion in CCl4 treated rats.
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